Nicotine Addiction Differential Diagnoses
- Author: R Gregory Lande, DO, FACN; Chief Editor: Glen L Xiong, MD more...
In addition to the conditions listed in the differential diagnosis, other problems to be considered include the following:
- Fetal growth retardation
- Atherosclerotic vascular disease
- Histiocytosis X
- Respiratory bronchitis
- Obstructive sleep apnea
- Idiopathic pneumothorax
- Low birth weight
- Perinatal mortality
Centers for Disease Control and Prevention. Cigarette Smoking in the United States. Available at http://www.cdc.gov/tobacco/campaign/tips/resources/data/cigarette-smoking-in-united-states.html#two. Accessed: February 06, 2014.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. 5th ed. Arlington, VA: American Psychiatric Association; 2013. 571-4.
Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008 Jan 23. CD000146. [Medline].
Fiore MC. Treating tobacco use and dependence: an introduction to the US Public Health Service Clinical Practice Guideline. Respir Care. 2000 Oct. 45(10):1196-9. [Medline].
Esson L, Leeder SR. The millennium development goals and tobacco control: an opportunity for global partnership. Geneva: World Health Organization (WHO); 2004.
World Health Organization. Why is tobacco a public health priority? A Tobacco Free Initiative; 2005. Available at http://www.who.int/tobacco/health_priority/en. Accessed: March 30, 2006.
[Guideline] Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, et al. Guidelines for the Primary Prevention of Stroke. A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2010 Dec 6. [Medline].
Glassman AH, Koob GF. Neuropharmacology. Psychoactive smoke. Nature. 1996 Feb 22. 379(6567):677-8. [Medline].
Picciotto MR, Brunzell DH, Caldarone BJ. Effect of nicotine and nicotinic receptors on anxiety and depression. Neuroreport. 2002 Jul 2. 13(9):1097-106. [Medline].
Weinberger AH, Pilver CE, Desai RA, Mazure CM, McKee SA. The relationship of major depressive disorder and gender to changes in smoking for current and former smokers: Longitudinal evaluation in the U.S. population. Addiction. 2012 Mar 19. [Medline].
Lande RG, Gragnani C. Nonpharmacologic approaches to the management of insomnia. J Am Osteopath Assoc. 2010 Dec. 110(12):695-701. [Medline].
Jaehne A, Loessl B, Bárkai Z, Riemann D, Hornyak M. Effects of nicotine on sleep during consumption, withdrawal and replacement therapy. Sleep Med Rev. 2009 Oct. 13(5):363-77. [Medline].
Fu SS, McFall M, Saxon AJ, Beckham JC, Carmody TP, Baker DG, et al. Post-traumatic stress disorder and smoking: a systematic review. Nicotine Tob Res. 2007 Nov. 9(11):1071-84. [Medline].
Bray RM, Pemberton MR, Lane ME, Hourani LL, Mattiko MJ, Babeu LA. Substance use and mental health trends among U.S. military active duty personnel: key findings from the 2008 DoD Health Behavior Survey. Mil Med. 2010 Jun. 175(6):390-9. [Medline].
Hermes ED, Wells TS, Smith B, Boyko EJ, Gackstetter GG, Miller SC, et al. Smokeless tobacco use related to military deployment, cigarettes and mental health symptoms in a large, prospective cohort study among US service members. Addiction. 2012 May. 107(5):983-94. [Medline].
Cook J, Jakupcak M, Rosenheck R, Fontana A, McFall M. Influence of PTSD symptom clusters on smoking status among help-seeking Iraq and Afghanistan veterans. Nicotine Tob Res. 2009 Oct. 11(10):1189-95. [Medline]. [Full Text].
Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality. Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. US Department of Health and Human Services. Available at http://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf. 2013; Accessed: July 15, 2016.
Peters J, Bromberg U, Schneider S, Brassen S, Menz M, Banaschewski T, et al. Lower ventral striatal activation during reward anticipation in adolescent smokers. Am J Psychiatry. 2011 May. 168(5):540-9.
Bandiera FC, Richardson AK, Lee DJ, He JP, Merikangas KR. Secondhand Smoke Exposure and Mental Health Among Children and Adolescents. Arch Pediatr Adolesc Med. 2011. 165(4):332-338.
U.S. Department of Health and Human Services. Preventing Tobacco Use Among Youth and Young Adults: A Report of the Surgeon General. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2012. 2012. Available at http://www.surgeongeneral.gov/library/preventing-youth-tobacco-use/full-report.pdf.
Harrison L. E-Cigarette-Related Poison Center Calls Surge. Medscape Medical News. Available at http://www.medscape.com/viewarticle/823052. Accessed: April 9, 2014.
Farley AC, Hajek P, Lycett D, Aveyard P. Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev. 2012 Jan 18. 1:CD006219. [Medline].
Dale LC, Schroeder DR, Wolter TD. Weight change after smoking cessation using variable doses of transdermal nicotine replacement. J Gen Intern Med. 1998 Jan. 13(1):9-15. [Medline].
Thomas RE, Baker P, Lorenzetti D. Family-based programmes for preventing smoking by children and adolescents. Cochrane Database Syst Rev. 2007 Jan 24. CD004493. [Medline].
Thomas R, Perera R. School-based programmes for preventing smoking. Cochrane Database Syst Rev. 2006 Jul 19. 3:CD001293. [Medline].
Sowden AJ, Arblaster L. Mass media interventions for preventing smoking in young people. Cochrane Database Syst Rev. 2000. CD001006. [Medline].
Cahill K, Moher M, Lancaster T. Workplace interventions for smoking cessation. Cochrane Database Syst Rev. 2008 Oct 8. CD003440. [Medline].
Lancaster T, Stead LF. Self-help interventions for smoking cessation. Cochrane Database Syst Rev. 2005 Jul 20. CD001118. [Medline].
Henningfield JE, Fant RV, Buchhalter AR. Pharmacotherapy for nicotine dependence. CA Cancer J Clin. 2005 Sep-Oct. 55(5):281-99; quiz 322-3, 325. [Medline].
Ebbert J, Montori VM, Erwin PJ, Stead LF. Interventions for smokeless tobacco use cessation. Cochrane Database Syst Rev. 2011 Feb 16;2:CD004306.
Counseling and interventions to prevent tobacco use and tobacco-caused disease in adults and pregnant women: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2009 Apr 21. 150(8):551-5. [Medline]. [Full Text].
Richmond RL, Kehoe L, de Almeida Neto AC. Three year continuous abstinence in a smoking cessation study using the nicotine transdermal patch. Heart. 1997 Dec. 78(6):617-8. [Medline].
Mahmarian JJ, Moye LA, Nasser GA, et al. Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia. J Am Coll Cardiol. 1997 Jul. 30(1):125-30. [Medline].
Ferguson SG, Gitchell JG, Shiffman S. Continuing to wear nicotine patches after smoking lapses promotes recovery of abstinence. Addiction. 2012 Jan 26. [Medline].
Stotts RC, Roberson PK, Hanna EY. A randomised clinical trial of nicotine patches for treatment of spit tobacco addiction among adolescents. Tob Control. 2003 Dec. 12 Suppl 4:IV11-5. [Medline].
Murray RP, Bailey WC, Daniels K, et al. Safety of nicotine polacrilex gum used by 3,094 participants in the Lung Health Study. Lung Health Study Research Group. Chest. 1996 Feb. 109(2):438-45. [Medline].
Etter JF, Huguelet P, Perneger TV, Cornuz J. Nicotine gum treatment before smoking cessation: a randomized trial. Arch Intern Med. 2009 Jun 8. 169(11):1028-34. [Medline]. [Full Text].
[Guideline] U.S. Department of Health and Human Services. Public Health Service. Clinical Practice Guideline: Treating Tobacco Use and Dependence: 2008. [Full Text].
Piper ME, Smith SS, Schlam TR, Fiore MC, Jorenby DE, Fraser D, et al. A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Arch Gen Psychiatry. 2009 Nov. 66(11):1253-62. [Medline].
Zhang B, Cohen JE, Bondy SJ, Selby P. Duration of nicotine replacement therapy use and smoking cessation: a population-based longitudinal study. Am J Epidemiol. 2015 Apr 1. 181(7):513-20. [Medline]. [Full Text].
Hughes JR, Stead LF, Lancaster T. Anxiolytics and antidepressants for smoking cessation. Cochrane Database Syst Rev. 2000. CD000031. [Medline].
Hurt RD, Sachs DP, Glover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med. 1997 Oct 23. 337(17):1195-202. [Medline].
Planer D, Lev I, Elitzur Y, et al. Bupropion for smoking cessation in patients with acute coronary syndrome. Arch Intern Med. 2011 Jun 27. 171(12):1055-60. [Medline].
Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2007 Jan 24. CD006103. [Medline].
Singh S, Loke YK, Spangler JG, Furberg CD. Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis. CMAJ. Available at http://www.cmaj.ca/content/early/2011/07/04/cmaj.110218.full.pdf+html. Accessed: July 5, 2011.
US Food and Drug Administration (FDA). Chantix (varenicline): Safety Communication – Updated safety review on the risk of cardiovascular adverse events. FDA MedWatch December 12, 2012. Available at http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm331626.htm.
Kornitzer M, Boutsen M, Dramaix M. Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Prev Med. 1995 Jan. 24(1):41-7. [Medline].
Hughes JR, Goldstein MG, Hurt RD, Shiffman S. Recent advances in the pharmacotherapy of smoking. JAMA. 1999 Jan 6. 281(1):72-6. [Medline].
Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med. 1999 Mar 4. 340(9):685-91. [Medline].
Bergen AW, Caporaso N. Cigarette smoking. J Natl Cancer Inst. 1999 Aug 18. 91(16):1365-75. [Medline].
Nabi Biopharmaceuticals. Nabi Biopharmaceuticals Announces Results of First NicVAX(R) Phase III Clinical Trial. Nabi Biopharmaceuticals. Available at http://phx.corporate-ir.net/phoenix.zhtml?c=100445&p=irol-newsArticle&ID=1586001&highlight=. Accessed: July 18, 2011.
Lancaster T, Stead LF. Mecamylamine (a nicotine antagonist) for smoking cessation. Cochrane Database Syst Rev. 2000. CD001009. [Medline].
Grimshaw GM, Stanton A. Tobacco cessation interventions for young people. Cochrane Database Syst Rev. 2006 Oct 18. CD003289. [Medline].
Brooks M. Drug Combo Boosts Early Quit Rates in Smokers. Available at http://www.medscape.com/viewarticle/818940.. Accessed: February 1, 2014.
Chatham-Stephens K, Law R, Taylor E, Melstrom P, Bunnell R, Wang B, et al. Notes from the field: calls to poison centers for exposures to electronic cigarettes - United States, september 2010-february 2014. MMWR Morb Mortal Wkly Rep. 2014 Apr 4. 63(13):292-3. [Medline].
Ebbert JO, Hatsukami DK, Croghan IT, Schroeder DR, Allen SS, Hays JT, et al. Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial. JAMA. 2014 Jan 8. 311(2):155-63. [Medline].
Reuters Staff. No Change in Tobacco Use Among U.S. Youth; E-Cigarettes Preferred. Medscape Medical News. Available at http://www.medscape.com/viewarticle/861994. April 15, 2016; Accessed: April 20, 2016.